Indicative Announcement on Obtaining EU Approval of a New Indication for a Drug Developed by the Holding Subsidiary

About this update from Shanghai Fosun Pharmaceutical (group) Co., Ltd. Class A

Indicative Announcement on Obtaining EU Approval of a New Indication for a Drug Developed by the Holding Subsidiary The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Shanghai Fosun Pharmaceutical (group) Co., Ltd. Class A